IBDEI0QD ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11851,1,2,0)
;;=2^J2916
;;^UTILITY(U,$J,358.3,11851,1,3,0)
;;=3^FERRIC GLUCOMATE 12.5MG
;;^UTILITY(U,$J,358.3,11852,0)
;;=J0129^^48^580^2^^^^1
;;^UTILITY(U,$J,358.3,11852,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11852,1,2,0)
;;=2^J0129
;;^UTILITY(U,$J,358.3,11852,1,3,0)
;;=3^ABATACEPT 10MG
;;^UTILITY(U,$J,358.3,11853,0)
;;=J1460^^48^580^43^^^^1
;;^UTILITY(U,$J,358.3,11853,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11853,1,2,0)
;;=2^J1460
;;^UTILITY(U,$J,358.3,11853,1,3,0)
;;=3^GAMMA GLOBULIN 1CC
;;^UTILITY(U,$J,358.3,11854,0)
;;=J1560^^48^580^44^^^^1
;;^UTILITY(U,$J,358.3,11854,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11854,1,2,0)
;;=2^J1560
;;^UTILITY(U,$J,358.3,11854,1,3,0)
;;=3^GAMMA GLOBULIN > 10CC
;;^UTILITY(U,$J,358.3,11855,0)
;;=J1561^^48^580^46^^^^1
;;^UTILITY(U,$J,358.3,11855,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11855,1,2,0)
;;=2^J1561
;;^UTILITY(U,$J,358.3,11855,1,3,0)
;;=3^GAMUNEX 500MG
;;^UTILITY(U,$J,358.3,11856,0)
;;=J2353^^48^580^82^^^^1
;;^UTILITY(U,$J,358.3,11856,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11856,1,2,0)
;;=2^J2353
;;^UTILITY(U,$J,358.3,11856,1,3,0)
;;=3^OCTREOTIDE 1MG
;;^UTILITY(U,$J,358.3,11857,0)
;;=J1930^^48^580^63^^^^1
;;^UTILITY(U,$J,358.3,11857,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11857,1,2,0)
;;=2^J1930
;;^UTILITY(U,$J,358.3,11857,1,3,0)
;;=3^LANREOTIDE 1MG
;;^UTILITY(U,$J,358.3,11858,0)
;;=J0561^^48^580^87^^^^1
;;^UTILITY(U,$J,358.3,11858,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11858,1,2,0)
;;=2^J0561
;;^UTILITY(U,$J,358.3,11858,1,3,0)
;;=3^PEN G BENZATHINE 100,000 UNITS
;;^UTILITY(U,$J,358.3,11859,0)
;;=J0558^^48^580^88^^^^1
;;^UTILITY(U,$J,358.3,11859,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11859,1,2,0)
;;=2^J0558
;;^UTILITY(U,$J,358.3,11859,1,3,0)
;;=3^PEN G BENZATHINE/PROCAINE 100,000 UNITS
;;^UTILITY(U,$J,358.3,11860,0)
;;=J2540^^48^580^89^^^^1
;;^UTILITY(U,$J,358.3,11860,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11860,1,2,0)
;;=2^J2540
;;^UTILITY(U,$J,358.3,11860,1,3,0)
;;=3^PEN G POTASSIUM 600,000 UNITS
;;^UTILITY(U,$J,358.3,11861,0)
;;=J2510^^48^580^90^^^^1
;;^UTILITY(U,$J,358.3,11861,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11861,1,2,0)
;;=2^J2510
;;^UTILITY(U,$J,358.3,11861,1,3,0)
;;=3^PEN G PROCAINE UP TO 600,000 UNITS
;;^UTILITY(U,$J,358.3,11862,0)
;;=J3370^^48^580^108^^^^1
;;^UTILITY(U,$J,358.3,11862,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11862,1,2,0)
;;=2^J3370
;;^UTILITY(U,$J,358.3,11862,1,3,0)
;;=3^VANCOMYCIN HCI 500MG
;;^UTILITY(U,$J,358.3,11863,0)
;;=J0696^^48^580^26^^^^1
;;^UTILITY(U,$J,358.3,11863,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11863,1,2,0)
;;=2^J0696
;;^UTILITY(U,$J,358.3,11863,1,3,0)
;;=3^CEFTRIAXONE SODIUM 250MG
;;^UTILITY(U,$J,358.3,11864,0)
;;=J0692^^48^580^23^^^^1
;;^UTILITY(U,$J,358.3,11864,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11864,1,2,0)
;;=2^J0692
;;^UTILITY(U,$J,358.3,11864,1,3,0)
;;=3^CEFEPIME HCL 500MG
;;^UTILITY(U,$J,358.3,11865,0)
;;=J2185^^48^580^70^^^^1
;;^UTILITY(U,$J,358.3,11865,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11865,1,2,0)
;;=2^J2185
;;^UTILITY(U,$J,358.3,11865,1,3,0)
;;=3^MEROPENEM 100MG
;;^UTILITY(U,$J,358.3,11866,0)
;;=J1200^^48^580^33^^^^1
;;^UTILITY(U,$J,358.3,11866,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11866,1,2,0)
;;=2^J1200
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QD 3767 printed Sep 23, 2025@19:29:42 Page 2
IBDEI0QD ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11851,1,2,0)
+2 ;;=2^J2916
+3 ;;^UTILITY(U,$J,358.3,11851,1,3,0)
+4 ;;=3^FERRIC GLUCOMATE 12.5MG
+5 ;;^UTILITY(U,$J,358.3,11852,0)
+6 ;;=J0129^^48^580^2^^^^1
+7 ;;^UTILITY(U,$J,358.3,11852,1,0)
+8 ;;=^358.31IA^3^2
+9 ;;^UTILITY(U,$J,358.3,11852,1,2,0)
+10 ;;=2^J0129
+11 ;;^UTILITY(U,$J,358.3,11852,1,3,0)
+12 ;;=3^ABATACEPT 10MG
+13 ;;^UTILITY(U,$J,358.3,11853,0)
+14 ;;=J1460^^48^580^43^^^^1
+15 ;;^UTILITY(U,$J,358.3,11853,1,0)
+16 ;;=^358.31IA^3^2
+17 ;;^UTILITY(U,$J,358.3,11853,1,2,0)
+18 ;;=2^J1460
+19 ;;^UTILITY(U,$J,358.3,11853,1,3,0)
+20 ;;=3^GAMMA GLOBULIN 1CC
+21 ;;^UTILITY(U,$J,358.3,11854,0)
+22 ;;=J1560^^48^580^44^^^^1
+23 ;;^UTILITY(U,$J,358.3,11854,1,0)
+24 ;;=^358.31IA^3^2
+25 ;;^UTILITY(U,$J,358.3,11854,1,2,0)
+26 ;;=2^J1560
+27 ;;^UTILITY(U,$J,358.3,11854,1,3,0)
+28 ;;=3^GAMMA GLOBULIN > 10CC
+29 ;;^UTILITY(U,$J,358.3,11855,0)
+30 ;;=J1561^^48^580^46^^^^1
+31 ;;^UTILITY(U,$J,358.3,11855,1,0)
+32 ;;=^358.31IA^3^2
+33 ;;^UTILITY(U,$J,358.3,11855,1,2,0)
+34 ;;=2^J1561
+35 ;;^UTILITY(U,$J,358.3,11855,1,3,0)
+36 ;;=3^GAMUNEX 500MG
+37 ;;^UTILITY(U,$J,358.3,11856,0)
+38 ;;=J2353^^48^580^82^^^^1
+39 ;;^UTILITY(U,$J,358.3,11856,1,0)
+40 ;;=^358.31IA^3^2
+41 ;;^UTILITY(U,$J,358.3,11856,1,2,0)
+42 ;;=2^J2353
+43 ;;^UTILITY(U,$J,358.3,11856,1,3,0)
+44 ;;=3^OCTREOTIDE 1MG
+45 ;;^UTILITY(U,$J,358.3,11857,0)
+46 ;;=J1930^^48^580^63^^^^1
+47 ;;^UTILITY(U,$J,358.3,11857,1,0)
+48 ;;=^358.31IA^3^2
+49 ;;^UTILITY(U,$J,358.3,11857,1,2,0)
+50 ;;=2^J1930
+51 ;;^UTILITY(U,$J,358.3,11857,1,3,0)
+52 ;;=3^LANREOTIDE 1MG
+53 ;;^UTILITY(U,$J,358.3,11858,0)
+54 ;;=J0561^^48^580^87^^^^1
+55 ;;^UTILITY(U,$J,358.3,11858,1,0)
+56 ;;=^358.31IA^3^2
+57 ;;^UTILITY(U,$J,358.3,11858,1,2,0)
+58 ;;=2^J0561
+59 ;;^UTILITY(U,$J,358.3,11858,1,3,0)
+60 ;;=3^PEN G BENZATHINE 100,000 UNITS
+61 ;;^UTILITY(U,$J,358.3,11859,0)
+62 ;;=J0558^^48^580^88^^^^1
+63 ;;^UTILITY(U,$J,358.3,11859,1,0)
+64 ;;=^358.31IA^3^2
+65 ;;^UTILITY(U,$J,358.3,11859,1,2,0)
+66 ;;=2^J0558
+67 ;;^UTILITY(U,$J,358.3,11859,1,3,0)
+68 ;;=3^PEN G BENZATHINE/PROCAINE 100,000 UNITS
+69 ;;^UTILITY(U,$J,358.3,11860,0)
+70 ;;=J2540^^48^580^89^^^^1
+71 ;;^UTILITY(U,$J,358.3,11860,1,0)
+72 ;;=^358.31IA^3^2
+73 ;;^UTILITY(U,$J,358.3,11860,1,2,0)
+74 ;;=2^J2540
+75 ;;^UTILITY(U,$J,358.3,11860,1,3,0)
+76 ;;=3^PEN G POTASSIUM 600,000 UNITS
+77 ;;^UTILITY(U,$J,358.3,11861,0)
+78 ;;=J2510^^48^580^90^^^^1
+79 ;;^UTILITY(U,$J,358.3,11861,1,0)
+80 ;;=^358.31IA^3^2
+81 ;;^UTILITY(U,$J,358.3,11861,1,2,0)
+82 ;;=2^J2510
+83 ;;^UTILITY(U,$J,358.3,11861,1,3,0)
+84 ;;=3^PEN G PROCAINE UP TO 600,000 UNITS
+85 ;;^UTILITY(U,$J,358.3,11862,0)
+86 ;;=J3370^^48^580^108^^^^1
+87 ;;^UTILITY(U,$J,358.3,11862,1,0)
+88 ;;=^358.31IA^3^2
+89 ;;^UTILITY(U,$J,358.3,11862,1,2,0)
+90 ;;=2^J3370
+91 ;;^UTILITY(U,$J,358.3,11862,1,3,0)
+92 ;;=3^VANCOMYCIN HCI 500MG
+93 ;;^UTILITY(U,$J,358.3,11863,0)
+94 ;;=J0696^^48^580^26^^^^1
+95 ;;^UTILITY(U,$J,358.3,11863,1,0)
+96 ;;=^358.31IA^3^2
+97 ;;^UTILITY(U,$J,358.3,11863,1,2,0)
+98 ;;=2^J0696
+99 ;;^UTILITY(U,$J,358.3,11863,1,3,0)
+100 ;;=3^CEFTRIAXONE SODIUM 250MG
+101 ;;^UTILITY(U,$J,358.3,11864,0)
+102 ;;=J0692^^48^580^23^^^^1
+103 ;;^UTILITY(U,$J,358.3,11864,1,0)
+104 ;;=^358.31IA^3^2
+105 ;;^UTILITY(U,$J,358.3,11864,1,2,0)
+106 ;;=2^J0692
+107 ;;^UTILITY(U,$J,358.3,11864,1,3,0)
+108 ;;=3^CEFEPIME HCL 500MG
+109 ;;^UTILITY(U,$J,358.3,11865,0)
+110 ;;=J2185^^48^580^70^^^^1
+111 ;;^UTILITY(U,$J,358.3,11865,1,0)
+112 ;;=^358.31IA^3^2
+113 ;;^UTILITY(U,$J,358.3,11865,1,2,0)
+114 ;;=2^J2185
+115 ;;^UTILITY(U,$J,358.3,11865,1,3,0)
+116 ;;=3^MEROPENEM 100MG
+117 ;;^UTILITY(U,$J,358.3,11866,0)
+118 ;;=J1200^^48^580^33^^^^1
+119 ;;^UTILITY(U,$J,358.3,11866,1,0)
+120 ;;=^358.31IA^3^2
+121 ;;^UTILITY(U,$J,358.3,11866,1,2,0)
+122 ;;=2^J1200
